CommentaryA Critique of Surgical Cytoreduction in Advanced Ovarian Cancer☆
References (51)
- et al.
Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: a prospective randomized trial
Obstet Gynecol
(1996) - et al.
Electrosurgical debulking of ovarian cancer: a new technique using the argon beam coagulator
Gynecol Oncol
(1990) - et al.
Splenectomy as part of cytoreductive surgery for ovarian carcinoma
Gynecol Oncol
(1995) The cavitational ultasonic surgical aspirator for cytoreduction in advanced ovarian cancer
Am J Obstet Gynecol
(1992)- et al.
The pelvic retroperitoneal approach in the treatment of advanced ovarian cancer
Obstet Gynecol
(1996) - et al.
Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma
Gynecol Oncol
(1985) - et al.
Reproducibility of tumor measurements in ovarian cancer: a study of interobserver variability
Gynecol Oncol
(1994) - et al.
The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery
Gynecol Oncol
(1994) - et al.
The impact of subspecialty training on the management of advanced ovarian cancer
Gynecol Oncol
(1992) - et al.
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a gynecologic oncology group study
Gynecol Oncol
(1992)
The influence of cytoreductive surgery on progression-free interval and survival in epithelial ovarian cancer
Bailliere's Clin Obstet Gynecol
(1989)
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study
Gynecol Oncol
(1998)
Does aggressive therapy improve survival in suboptimal stage IIIc/IV ovarian cancer? A Canadian–American comparative study
Gynecol Oncol
(1995)
Debulking surgery: does it increase the quality of survival?
Gynecol Oncol
(1982)
Extensive primary cytoreductive surgery of advanced epithelial ovarian cancer
Gynecol Oncol
(1994)
Neoadjuvant chemotherapy for advanced ovarian cancer
Gynecol Oncol
(1994)
Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer
Gynecol Oncol
(1991)
Stage III epithelial ovarian cancer: the role of maximal surgical reduction
Gynecol Oncol
(1984)
Cisplatin, methotrexate and 5-fluorouracil combination chemotherapy for advanced ovarian cancer
Gynecol Oncol
(1985)
The cyclophosphamide, hexamethylmelamine, 5-fluorouracil regimen in the treatment of advanced and recurrent ovarian cancer
Gynecol Oncol
(1985)
Review of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute
Am J Obstet Gynecol
(1979)
Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma
Lancet
(1984)
Cytoreductive surgery for common epithelial tumours of the ovary
Clin Obstet Gynecol
(1983)
Role of cytoreductive surgical treatment in the management of advanced ovarian cancer
Cancer Treat Rep
(1979)
Extensive cytoreductive surgery in advanced ovarian carcinoma
Eur J Gynecol Oncol
(1997)
Cited by (168)
Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement
2021, Gynecologic OncologyA radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer
2020, Journal of Visceral SurgeryThe value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer
2018, European Journal of Cancer
- ☆
Presented at “Controversies in First-Line Therapy for Ovarian Carcinoma—Revisited,” Gynecologic Oncology Group Educational Symposium, July 16, 1998, Toronto, Canada.
Copyright © 2000 Academic Press. All rights reserved.